Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledgeSource: Eur Respir J, 55 (4) 1901592; 10.1183/13993003.01592-2019 Year: 2020
The impact of sensitization to Staphylococcus aureus–derived enterotoxins on allergic and respiratory disorders Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020
Development of an innovative, Staphylococcus aureus enterotoxin B (SEB)-aided rat model of atopic asthma Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017
The effect of polyvalent mechanical bacterial lysate on the reduction of nasal Staphylococcus aureus carriage in children with pollen allergic rhinitis Source: International Congress 2019 – Asthma biomarkers, diagnostics and risk factors Year: 2019
The functional role of IgE to staphylococcus aureus enterotoxins in severe asthma Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
Moulds and Staphylococcus aureus enterotoxins are relevant allergens to affect Type 2 inflammation and clinical outcomes in chronic rhinosinusitis patients Source: ERJ Open Res, 6 (4) 00265-2020; 10.1183/23120541.00265-2020 Year: 2020
Nasopharyngeal carriage of Streptococcus pneumoniae by children with underlying pulmonary diseases Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005
What lessons have been learnt from animal models of MRSA in the lung? Source: Eur Respir J 2010; 35: 198-201 Year: 2010
Prevalence and impact on FEV1 decline of methicillin-resistant Staphylococcus aureus infection in patients with cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011
Staphylococcus aureus in children with tracheostomy : Correlation with clinical outcomes Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others Year: 2019
Time-dependent response of airway epithelial cells to Staphylococcus aureus Source: Eur Respir J 2004; 24: Suppl. 48, 555s Year: 2004
Cell wall deficiency: a novel mechanism for methicillin resistance in Staphylococcus aureus Source: Eur Respir J 2005; 26: Suppl. 49, 94s Year: 2005
Pseudomonas aeruginosa from CF airways uses various strategies to outcompete staphylococcus aureus Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016
Molecular epidemiology and antimicrobial resistance of methicillin-resistant staphylococcus aureus isolated from nasal swab at intensive care unit Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008
Mechanisms of acquisition of resistance in Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006
Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006
Successful eradication of methicillin-resistant staphylococcus aureus in chronically colonized cystic fibrosis patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
Detection of alpha-hemolysin in Staphylococcus aureus derived respiratory strains: correlation with microbiological and clinical variables Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017
What is MRSA? Source: Eur Respir J 2009; 34: 1190-1196 Year: 2009